It is being tested to see if it reduces blood-clot risks.
Aspirin, the common painkiller, is being tested as a potential treatment for patients hospitalized with the coronavirus to see if it reduces the risk of blood clots. It is known to be a blood thinner, and will be given to patients enrolled in a particular study in the U.K., researchers said.
In the test, about 2,000 patients will be given aspirin in addition to standard-of-care treatment. The results will be compared with 2,000 patients who only received standard-of-care treatment and, after 28 days, the mortality rate will be assessed, as well as the impact on hospital stay and need for ventilation.
According to the FDA, aspirin, when used daily, has been shown to reduce the risk of heart attack, clot-related strokes, and other blood flow issues in patients who have cardiovascular disease or who have already had a heart attack or stroke. It is also used frequently as a pain reliever and to reduce fever or inflammation.
The researchers, who expect results in a few months, say there is a clear rationale for believing that aspirin might be beneficial, and it is safe, inexpensive, and widely available.
As the Lord Leads, Pray with Us…
- For the researchers and patients who will be going through the trial on the effectiveness of aspirin in dealing with aspects of the coronavirus.
- For other researchers, medical professionals, and laboratories who are working on therapeutics to combat the virus.
- For those developing vaccines that will soon be ready for early distribution to healthcare workers and the most vulnerable.
Sources: Market Watch, Forbes
